53 related articles for article (PubMed ID: 37477348)
1. Anti-amyloidogenic amphipathic arginine-dehydrophenylalanine spheres capped selenium nanoparticles as potent therapeutic moieties for Alzheimer's disease.
Kour A; Tiwari V; Aggarwal N; Sekhar Panda H; Kumar A; Tiwari S; Chauhan VS; Shukla S; Panda JJ
Nanoscale; 2023 Aug; 15(30):12748-12770. PubMed ID: 37477348
[TBL] [Abstract][Full Text] [Related]
2. Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review.
Vicente-Zurdo D; Rosales-Conrado N; León-González ME
Talanta; 2024 Mar; 269():125519. PubMed ID: 38086100
[TBL] [Abstract][Full Text] [Related]
3. Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1-42 Polymerization.
Yuan N; Ye L; Sun Y; Wu H; Xiao Z; Fu W; Chen Z; Pei Y; Min Y; Wang D
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108834
[TBL] [Abstract][Full Text] [Related]
4. Triazole-Peptide Conjugate as a Modulator of Aβ-Aggregation, Metal-Mediated Aβ-Aggregation, and Cytotoxicity.
Mann S; Kaur A; Kaur A; Priyadarshi N; Goyal B; Singhal NK; Goyal D
ACS Chem Neurosci; 2023 May; 14(9):1631-1645. PubMed ID: 37040092
[TBL] [Abstract][Full Text] [Related]
5. Futuristic Alzheimer's therapy: acoustic-stimulated piezoelectric nanospheres for amyloid reduction.
Sharma M; Choudhury S; Babu A; Gupta V; Sengupta D; Ali SA; Dhokne MD; Datusalia AK; Mandal D; Panda JJ
Biomater Sci; 2024 Mar; 12(7):1801-1821. PubMed ID: 38407241
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory Impacts of Fulvic Acid-Coated Iron Oxide Nanoparticles on the Amyloid Fibril Aggregations.
Jomehpour D; Sheikhlary S; Heydari E; Ara MHM
IEEE Trans Nanobioscience; 2024 Jan; 23(1):3-10. PubMed ID: 37058385
[TBL] [Abstract][Full Text] [Related]
7. Delivering Crocetin across the Blood-Brain Barrier by Using γ-Cyclodextrin to Treat Alzheimer's Disease.
Wong KH; Xie Y; Huang X; Kadota K; Yao XS; Yu Y; Chen X; Lu A; Yang Z
Sci Rep; 2020 Feb; 10(1):3654. PubMed ID: 32107408
[TBL] [Abstract][Full Text] [Related]
8. Amyloid β-Peptide Segment Conjugated Side-Chain Proline-Based Polymers as Potent Inhibitors in Lysozyme Amyloidosis.
Nayak K; Ghosh P; Barman S; Sudhamalla B; Theato P; De P
Bioconjug Chem; 2024 Mar; 35(3):312-323. PubMed ID: 38420925
[TBL] [Abstract][Full Text] [Related]
9. Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer's Disease.
Sonawane SK; Ahmad A; Chinnathambi S
ACS Omega; 2019 Jul; 4(7):12833-12840. PubMed ID: 31460408
[TBL] [Abstract][Full Text] [Related]
10. Degradation of fibrin-β amyloid co-aggregate: A novel function attributed to ubiquitin.
Bhattacharjee P; De D; Bhattacharyya D
Biochim Biophys Acta Mol Cell Res; 2018 Jul; 1865(10):1465-1478. PubMed ID: 30031899
[TBL] [Abstract][Full Text] [Related]
11. The role of cadmium in the pathogenesis of myeloid leukemia in individuals with anemia, deficiencies in vitamin D, zinc, and low calcium dietary intake.
Djulejic V; Petrovic B; Jevtic J; Vujacic M; Clarke BL; Cirovic A; Cirovic A
J Trace Elem Med Biol; 2023 Sep; 79():127263. PubMed ID: 37499549
[TBL] [Abstract][Full Text] [Related]
12. Metals linked with the most prevalent primary neurodegenerative dementias in the elderly: A narrative review.
Mateo D; Marquès M; Torrente M
Environ Res; 2023 Nov; 236(Pt 1):116722. PubMed ID: 37487923
[TBL] [Abstract][Full Text] [Related]
13. Combined Donepezil with Astaxanthin via Nanostructured Lipid Carriers Effective Delivery to Brain for Alzheimer's Disease in Rat Model.
Shehata MK; Ismail AA; Kamel MA
Int J Nanomedicine; 2023; 18():4193-4227. PubMed ID: 37534058
[TBL] [Abstract][Full Text] [Related]
14. Combined effect of trehalose and spermidine to alleviate zinc toxicity in
Alamer KH
3 Biotech; 2023 Aug; 13(8):288. PubMed ID: 37525633
[TBL] [Abstract][Full Text] [Related]
15. Feasibility of virtual Alzheimer's biomarker disclosure: Findings from an observational cohort.
Erickson CM; Chin NA; Rosario HL; Peterson A; Johnson SC; Clark LR
Alzheimers Dement (N Y); 2023; 9(3):e12413. PubMed ID: 37521522
[TBL] [Abstract][Full Text] [Related]
16. Bioinformatics and Experimental Identification of
Ma M; Xie D; Zhao J
J Integr Neurosci; 2023 Jul; 22(4):105. PubMed ID: 37519165
[TBL] [Abstract][Full Text] [Related]
17. FUS-mediated blood-brain barrier disruption for delivering anti-Aβ antibodies in 5XFAD Alzheimer's disease mice.
Antoniou A; Stavrou M; Evripidou N; Georgiou E; Kousiappa I; Koupparis A; Papacostas SS; Kleopa KA; Damianou C
J Ultrasound; 2024 Jun; 27(2):251-262. PubMed ID: 37516718
[TBL] [Abstract][Full Text] [Related]
18. Discovery of triazole-bridged aryl adamantane analogs as an intriguing class of multifunctional agents for treatment of Alzheimer's disease.
Gutti G; Leifeld J; Kakarla R; Bajad NG; Ganeshpurkar A; Kumar A; Krishnamurthy S; Klein-Schmidt C; Tapken D; Hollmann M; Singh SK
Eur J Med Chem; 2023 Nov; 259():115670. PubMed ID: 37515920
[TBL] [Abstract][Full Text] [Related]
19. Inconsistent Effects of Glatiramer Acetate Treatment in the 5xFAD Mouse Model of Alzheimer's Disease.
Karaahmet B; Olschowka JA; O'Banion MK
Pharmaceutics; 2023 Jun; 15(7):. PubMed ID: 37513996
[TBL] [Abstract][Full Text] [Related]
20. Screening for Novel Inhibitors of Amyloid Beta Aggregation and Toxicity as Potential Drugs for Alzheimer's Disease.
Sharari S; Vaikath NN; Tsakou M; Ghanem SS; Vekrellis K
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
